STOCK TITAN

DR Reddy's insiders move large ADS holdings into family trusts; ownership percentages disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Amendment No. 6 to Schedule 13D reports ownership and transfer details for DR REDDY'S LABORATORIES LTD ADSs (ticker RDY). On September 17, 2025, G.V. Prasad transferred 96,095,920 post-split shares to GVP Family Trust and K. Satish Reddy transferred 75,630,620 post-split shares to VSD Family Trust for estate planning and family succession. After these transfers, reporting persons may be deemed to beneficially own between approximately 9.07% and 13.58% of outstanding post-split shares depending on constructive ownership through trusts and HUFs. The filing explains source of shares (merger-related distributions, prior transfers, inheritance) and trust deeds that include ROFR and tag-along rights.

Positive

  • Clear disclosure of transfers, constructive ownership percentages and sources of shares (merger, prior transfers, inheritance)
  • Trust deeds include reciprocal ROFR and tag-along rights that preserve family coordination and provide clarity on future transfers
  • Estate planning rationale disclosed, indicating transfers were for succession and family planning rather than market-driven sales

Negative

  • High insider concentration: combined family/trust holdings represent double-digit percentages (e.g., 11.51% and 9.06%), which may limit free float
  • Limited change in control clarity: while disclaimers are made, trustees retain voting/dispositive power which maintains concentrated influence without clear independent oversight

Insights

TL;DR: Major family shareholders transferred large holdings into family trusts for succession; governance rights and transfer restrictions are disclosed.

The filing documents material intra-family transfers that do not indicate a change in control but reshape direct legal ownership. Trust deeds include reciprocal ROFR and tag-along protections, preserving inter-family transfer coordination and limiting third-party sales without notice to the other family trust. Constructive ownership disclosures and Rule 13d-4 disclaimers are properly stated, clarifying who retains voting and dispositive power. For governance, these moves formalize succession and maintain concentrated insider influence through trustee roles.

TL;DR: Substantial share transfers to family trusts increase concentrated insider holdings (single-family blocks of ~11.5% and ~9.1%).

The Amendment quantifies post-split holdings precisely: GVP Family Trust holds 96,095,920 ADSs (~11.51%) and VSD Family Trust holds 75,630,620 ADSs (~9.06%). Reporting persons may be deemed to beneficially own up to ~13.58% and ~13.04% respectively when including HUF interests and direct holdings. The source of those shares is traceable to the 2022 merger distributions, prior transfers and inheritance, reducing ambiguity on provenance. No purchases occurred in the prior 60 days, indicating these are estate-planning transfers rather than market accumulation or divestiture.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
* Effective October 28, 2024, Dr. Reddy's Laboratories Limited (the "Company") implemented a 1:5 forward stock split, pursuant to which each of the Company's equity shares of Rs.5 each (each, a "Pre-Split Share") was split into five (5) equity shares of Rs.1 each (each, a "Post-Split Share"). As a result, (a) the 19,219,184 Pre-Split Shares which had been directly held by Mr. G.V. Prasad were increased to 96,095,920 Post-Split Shares, and (b) the 2,543,418 Pre-Split Shares directly held by the G.V. Prasad HUF (which Mr. G.V. Prasad may have been deemed to beneficially own) were increased to 12,717,090 Post-Split Shares. On September 17, 2025, Mr. G.V. Prasad transferred all 96,095,920 of his Post-Split Shares to GVP Family Trust. As a result, Mr. G.V. Prasad has ceased to directly hold any equity shares of the Company, but may be deemed to beneficially own both (i) the 96,095,920 Post-Split Shares directly held by the GVP Family Trust, and (ii) the 12,717,090 Post-Split Shares directly held by the G.V. Prasad HUF. Mr. G.V. Prasad disclaims such beneficial ownership pursuant to Rule 13d-4.


SCHEDULE 13D




Comment for Type of Reporting Person:
* Effective October 28, 2024, the Company implemented a 1:5 forward stock split, pursuant to which each of the Company's Pre-Split Shares (as defined above) was split into five (5) Post-Split Shares (as defined above). As a result, (a) the 15,126,124 Pre-Split Shares which were directly held by Mr. K. Satish Reddy as a result of May 22, 2024 transfer from the APS Trust were increased to 75,630,620 Post-Split Shares, (b) the 901,002 Pre-Split Shares which Mr. K. Satish Reddy had otherwise directly held at the time of the stock split were increased to 4,505,010, and (c) the 5,523,677 Pre-Split Shares directly held by the K. Satish Reddy HUF (which Mr. K. Satish Reddy may have been deemed to beneficially own) was increased to 27,618,385 Post-Split Shares. On September 17, 2025, Mr. K. Satish Reddy transferred to VSD Family Trust all 75,630,620 of the Post-Split Shares which he had received from the APS Trust. Mr. K. Satish Reddy retained his other 4,505,010 Post-Split Shares, along with another 5,602,495 Post-Split Shares which were transferred to him on March 18, 2025 as an inheritance from his mother, Mrs. Samrajyam Reddy Kalam. Accordingly, Mr. K. Satish Reddy now directly holds a total of 10,107,505 Post-Split Shares. As a result, Mr. K. Satish Reddy may be deemed to beneficially own (i) the 10,107,505 Post-Split Shares directly held by him, (ii) the 75,630,620 Post-Split Shares directly held by the VSD Family Trust, and (iii) the 27,618,385 Post-Split Shares directly held by the K. Satish Reddy HUF. Mr. K. Satish Reddy disclaims beneficial ownership of the Post-Split Shares referenced in the foregoing clauses (ii) and (iii), pursuant to Rule 13d-4.


SCHEDULE 13D




Comment for Type of Reporting Person:
*On September 17, 2025, Mr. G.V. Prasad transferred to GVP Family Trust a total of 96,095,920 Post-Split Shares (as defined above). As a result, GVP Family Trust directly holds a total of 96,095,920 Post-Split Shares.


SCHEDULE 13D




Comment for Type of Reporting Person:
*On September 17, 2025, Mr. K. Satish Reddy transferred to VSD Family Trust a total of 75,630,620 Post-Split Shares (as defined above). As a result, VSD Family Trust directly holds a total of 75,630,620 Post-Split Shares.


SCHEDULE 13D




Comment for Type of Reporting Person:
* Mrs. G. Anuradha, wife of Mr. G.V. Prasad,(i) directly holds 46,025 post splits shares and (ii) she may be deemed to beneficially own the 96,095,920 Post-Split Shares directly held by the GVP Family Trust. Mrs. G. Anuradha disclaims such beneficial ownership pursuant to Rule 13d-4.


SCHEDULE 13D




Comment for Type of Reporting Person:
* Mrs. Deepti Reddy, wife of Mr. K. Satish Reddy, (i) directly holds 25,700 post splits shares and (ii) she may be deemed to beneficially own the 75,630,620 Post-Split Shares directly held by the VSD Family Trust. Mrs. Deepti Reddy disclaims such beneficial ownership pursuant to Rule 13d-4.


SCHEDULE 13D


G.V. Prasad
Signature:/s/ G.V. Prasad
Name/Title:G.V. Prasad
Date:09/18/2025
K. Satish Reddy
Signature:/s/ K. Satish Reddy
Name/Title:K. Satish Reddy
Date:09/18/2025
GVP Family Trust
Signature:/s/ G.V. Prasad
Name/Title:G.V. Prasad/Trustee
Date:09/18/2025
VSD Family Trust
Signature:/s/ K. Satish Reddy
Name/Title:K. Satish Reddy/Trustee
Date:09/18/2025
G. Anuradha
Signature:/s/ G. Anuradha
Name/Title:G. Anuradha
Date:09/18/2025
Deepti Reddy
Signature:/s/ Deepti Reddy
Name/Title:DEEPTI REDDY
Date:09/18/2025
Comments accompanying signature:
Attention: Intentional misstatements or omissions of act constitute federal violations (see 18 U.S.C. 1001).

FAQ

What transfers are reported in the RDY Schedule 13D/A?

G.V. Prasad transferred 96,095,920 post-split shares to GVP Family Trust and K. Satish Reddy transferred 75,630,620 post-split shares to VSD Family Trust on September 17, 2025.

How much of DR Reddy's (RDY) outstanding shares do these reporting persons beneficially own?

Reported constructive ownership ranges from approximately 9.07% to 13.58% depending on the reporting person and inclusion of trust/HUF holdings.

Why were the shares transferred to family trusts according to the filing?

The transfers were made for estate planning and family succession purposes to streamline transfer of family assets and business interests.

Do the trust deeds contain any transfer restrictions for RDY shares?

Yes. The GVP and VSD Family Trust deeds provide reciprocal rights of first refusal and tag-along rights on sales to outside shareholders.

Did the reporting persons purchase additional RDY shares in the past 60 days?

No. The filing states that none of the reporting persons purchased post-split shares within the past 60 days.
Dr Reddys Labs

NYSE:RDY

RDY Rankings

RDY Latest News

RDY Latest SEC Filings

RDY Stock Data

11.05B
832.53M
13.54%
1.14%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
India
Hyderabad